Adam J. Schoenfeld - Concepedia

Author

Adam J. Schoenfeld

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

A Schoenfeld, A. Schoenfeld, A.J. Schoenfeld, Adam J. Schoenfeld, Adam J Schoenfeld, Adam J. Schoenfeld, Adam Jacob Schoenfeld, Adam Schoenfeld, Andrew J. Schoenfeld, Anna Parks

710

Publications

6.8K

Citations

H-Index

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Cornell University Dana-Farber Cancer Institute Harvard University Massachusetts General Hospital

About

Adam J. Schoenfeld is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	25	2.2K
2	Health Sciences	7	7	418
3	Engineering	2	2	25
4	Natural Sciences	1	1	10
5	Public Health	1	1	14

Adam J. Schoenfeld

Publications

4.7K

Citations

H-Index

Page 1

	Year	Citations
Severe immune-related adverse events are common with sequential PD-(L)1 blockade and osimertinib Adam J. Schoenfeld, Kathryn C. Arbour, Hira Rizvi, Annals of Oncology Clinical ImmunologyAutoimmune DiseaseImmunologyImmune Checkpoint InhibitorAutoimmunity	2019	401
Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non–Small-Cell Lung Cancer in CheckMate 227 Julie R. Brahmer, Jong-Seok Lee, Tudor–Eliade Ciuleanu, Journal of Clinical Oncology	2022	345
SMARCA4-Deficient Thoracic Sarcomatoid Tumors Represent Primarily Smoking-Related Undifferentiated Carcinomas Rather Than Primary Thoracic Sarcomas Natasha Rekhtman, Joseph Montecalvo, Jason C. Chang, Journal of Thoracic Oncology	2019	292
COVID-19 in patients with lung cancer Jie Luo, Hira Rizvi, Isabel R. Preeshagul, Annals of Oncology MedicineCovid-19 PandemicCovid-19 EpidemiologyOncologyLung Cancer	2020	267
The Genomic Landscape of <i>SMARCA4</i> Alterations and Associations with Outcomes in Patients with Lung Cancer Adam J. Schoenfeld, Chai Bandlamudi, Jessica A. Lavery, Clinical Cancer Research	2020	265
Non-viral precision T cell receptor replacement for personalized cell therapy Susan P. Foy, Kyle Jacoby, Daniela A. Bota, Nature	2022	252
The superiority of conservative resection and adjuvant radiation for craniopharyngiomas Adam J. Schoenfeld, Melike Pekmezci, Michael J. Barnes, Journal of Neuro-Oncology Skull BaseConservative ResectionOphthalmologyRadiation TherapyMedicine	2012	188
Combined JAK inhibition and PD-1 immunotherapy for non–small cell lung cancer patients Divij Mathew, Melina E. Marmarelis, Caitlin Foley, Science Persistent Inflammation RefractoryImmunologyImmunologic MechanismImmunotherapeuticsImmune Cell Therapy	2024	160
Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer Danish Memon, Adam J. Schoenfeld, Darwin Ye, Cancer Cell ImmunologyImmunoeditingImmunotherapeuticsImmunotherapyCancer Biology	2024	146
Spectrum of Mechanisms of Resistance to Crizotinib and Lorlatinib in <i>ROS1</i> Fusion–Positive Lung Cancer Noura J. Choudhury, Satoshi Yoda, Viola W. Zhu, Clinical Cancer Research	2021	132

Page 1